More than 100 veterans last year filed a bombshell lawsuit against several drugmakers, alleging they financed terrorism by paying bribes to win contracts with the Iraqi Ministry of Health. Now, the Department of Justice is investigating similar claims, according to an AstraZeneca securities filing that says it’s part of the probe.

In the SEC document, the British drugmaker said it received an inquiry from the DOJ in “connection with an anti-corruption investigation relating to activities in Iraq, including interactions with the Iraqi government and certain of the same matters” as those in the lawsuit. An AZ spokesperson on Tuesday told FiercePharma the company has a “robust and dynamic compliance program, and we refuse to tolerate bribery or any other form of corruption.”

Read More